Kaiser Permanente's Vaccine Study Center and Division of Research, both based in Oakland, are conducting the trial in concert with Pfizer and BioNTech, which co-developed the vaccine that will be used in the trial.
Read More 5San Jose Inside (https://www.sanjoseinside.com)